Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo

Area of Science:

• Immunology
• Microbiology
• Mycology

Background:

• Cryptococcus neoformans is an opportunistic fungal pathogen causing cryptococcosis.
• The fungal capsular component, glucuronoxylomannan (GXM), is detected in the serum during infection.
• Macrophages are involved in GXM uptake, suggesting receptor-mediated interactions.

Purpose of the Study:

• To investigate the role of specific GXM receptors in the clearance of GXM from the bloodstream.
• To determine the involvement of these receptors in the deposition of GXM in the liver and spleen.
• To assess the necessity of CD14, CD18, Toll-like receptor 2 (TLR2), and TLR4 in GXM immune disposition.

Main Methods:

• Utilized receptor-deficient mouse models lacking CD14, CD18, TLR2, or TLR4.
• Administered GXM to these mice and monitored its concentration in serum over time.
• Quantified GXM deposition in the liver and spleen of the mutant mice.
• Compared GXM pharmacokinetics and biodistribution between wild-type and receptor-deficient mice.

Main Results:

• While the kinetics of GXM redistribution showed some alterations in receptor-deficient mice, complete absence of any single receptor did not abolish serum clearance.
• Hepatosplenic accumulation of GXM occurred even in the absence of the studied receptors.
• No single receptor (CD14, CD18, TLR2, TLR4) was found to be absolutely essential for GXM serum clearance or organ deposition.

Conclusions:

• The clearance of GXM from serum and its deposition in the liver and spleen are complex processes.
• CD14, CD18, TLR2, and TLR4 are not individually indispensable for the primary disposition of GXM.
• Further research is needed to elucidate the complete network of receptors and mechanisms involved in GXM immune handling.